Mural Oncology plc said on Tuesday it would stop clinical development of its lead cancer treatment, nemvaleukin, and look into strategic alternatives for the company.

GE HealthCare (Nasdaq: GEHC) announced today that it appointed Jeannette Bankes as president and CEO for its Patient Care ...

The judge’s decision came as the Trump administration has moved to end legal protections for migrants from many countries, ...

Dr. Roger Dansey Dr. Roger Dansey joins Ottimo Pharma Limited Board of Directors Dansey, a former senior executive at Pfizer ...

The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...

Verve Therapeutics has generated evidence its PCSK9 pivot could pay off. | Verve Therapeutics has generated evidence its ...

GE HealthCare announced Wednesday it has appointed Jeannette Bankes as president and CEO of its patient care solutions ...

GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025.

Stocks surged to one of their biggest gains since World War II after President Donald Trump paused his tariffs against most ...

Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more ...

Biting cuts came to the nation’s health and science agencies last week, with thousands of layoffs and millions in budget ...

Global drugmakers and MedTech companies bounced back after U.S. President Donald Trump issued a 90-day pause on reciprocal ...